CarboFix’s CarboClear hybrid posterior screw system earned 510(k) clearance from the FDA.
The system is cleared for use across indications including oncology, degenerative conditions, trauma, revision surgery and infections, according to an April 14 news release shared with Becker’s. It can be used for fixation spanning levels C1 through C7 and T1 through T3.
CarboClear screws combines a carbon fiber-reinforced PEEK screw shank with an ultrathin titanium shell and titanium tulip. It’s designed for artifact-reducing imaging to strengthen post-operative assessment and optimized radiation therapy planning.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
